%0 Journal Article
%T Genomically personalized therapy in head and neck cancer
%A Kyaw L. Aung
%A Lillian L. Siu
%J Archive of "Cancers of the Head & Neck".
%D 2016
%R 10.1186/s41199-016-0004-y
%X Genomically driven dysregulated pathways and potential matched therapies in HNSCC. Combination strategies currently being tested in ongoing clinical trials are also shown. Abbreviations: MAB, monoclonal antibody; TKI, tyrosine kinase inhibito
%K Cetuximab
%K PIK3CA Mutation
%K CCND1 Amplification
%K PIK3CA Amplification
%K Tumor Mutation Burden
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457141/